ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Revenue 2016–2024
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$178.0MFY2024 · since FY2016: $14.2M → $178.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $178.0M | +195.3% |
| FY2023 | $60.3M | +122.0% |
| FY2022 | $27.1M | +341.5% |
| FY2021 | $6.1M | +55.4% |
| FY2020 | $4.0M | +252.8% |
| FY2019 | $1.1M | -98.1% |
| FY2018 | $59.5M | +57.3% |
| FY2017 | $37.8M | +166.5% |
| FY2016 | $14.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ADAPY financial trends
ADAPY Net incomeADAPY Net marginADAPY Gross profitADAPY Gross marginADAPY Operating incomeADAPY Operating marginADAPY Operating cash flowADAPY Free cash flowADAPY Capital expendituresADAPY Return on equityADAPY Stock buybacksADAPY Dividends paidADAPY Total assetsADAPY Total liabilitiesADAPY Shareholders’ equityADAPY overview →